fbpx

Mumps Virus

Mumps Virus


Mump Virus

  • Paramyxovirus
  • Predilection for the glandular and nervous tissue.
  • Has only one serotype.
Mumps
  • Acute contagious disease
  • Characterized by nonsuppurative enlargement of one or both salivary glands.

Source of infection

  • Clinical and subclinical cases
  • Incubatory carrier seen
  • Man is the only natural host

Age group 

  • 5-15 years

Period of infectivity

  • 4-6 days before the onset of symptom to a week thereafter.Maximum infectivity is just before and at the onset of parotitis.

Mode of transmission

  • Droplet infection by respiratory route.

Incubation period

  • 14-18 days

Clinical manifestation

Parotitis 

  • Most common manifestation of mumps (in all age groups)
  • 30-40% of infections are sub-clinical
  • Characteristic presentation is pain and swelling in either one or both parotid glands.
  • Sublingual or submandibular glands may also be involved.

 Orchitis

  • 2nd most common manifestation of mumps 
  • Seen in postpubertal males.
  • Adult males carry an up to 30% risk that the testes may become infected
  • Half of these infections result in testicular atrophy, and in rare cases sterility can follow

Aseptic meningitis 

  • Common manifestation of mumps more common in children .

Dacryoadenitis

  • Most common ocular manifestation of mumps.

Complications of mumps

  • Sterlity
  • Spontaneous abortion in about 27% of cases during the first trimester of pregnancy.
  • Mild forms of meningitis.
  • Oophoritis (inflammation of ovaries).
  • Pancreatitis , manifesting as abdominal pain and vomiting
  • Encephalitis, very rare
  • Profound (91 dB or more) but rare sensorineural hearing loss, uni- or bilateral. 
  • Acute unilateral deafness occurs in about 0.005% of cases
  • Thyroiditis, neuritis, hepatitis
  • Myocarditis
  • Acquired aqueductal stenosis
Treatment
  • There is no specific treatment for mumps.
  • After the illness, life-long immunity to mumps generally occurs.

Mumps vaccine

  • 95 % effective live attenuated vaccine.
  • Widely-used live attenuated mumps vaccine strains include :
  • The Jeryl-Lynn
  • RIT 4385
  • Leningrad-3
  •  L-Zagreb 
  •  Urabe strains.
  • Contraindicated in pregnancy
  • The duration of long-term immunity is not known.
  • Routine immunization:
  • For children over 1 year of age
  • Either alone or in combination with other virus vaccines
  • e.g. in MMR vaccine or as a quadrivalent vaccine with varicella.
  • A second dose is recommended for children at 4-6 years of age i.e., before starting the school
Exam Question
 

Mump Virus

  • Paramyxovirus.
Source of infection
  • Clinical and subclinical cases
  • Incubatory carrier seen
  • Man is the only natural host

Incubation period

  • 14-18 days

Clinical manifestation

Parotitis 

  • Most common manifestation of mumps (in all age groups)
  • 30-40% of infections are sub-clinical
  • Characteristic presentation is pain and swelling in either one or both parotid glands.

 Orchitis

  • 2nd most common manifestation of mumps 
  • Seen in postpubertal males.
  • Half of these infections result in testicular atrophy, and in rare cases sterility can follow

Aseptic meningitis 

  • Common manifestation of mumps more common in children .

Dacryoadenitis

  • Most common ocular manifestation of mumps.

Complications of mumps

  • Sterlity
  • Spontaneous abortion in about 27% of cases during the first trimester of pregnancy.
  • Mild forms of meningitis.
  • Oophoritis (inflammation of ovaries).
  • Pancreatitis , manifesting as abdominal pain and vomiting
  • Encephalitis, very rare
  • Profound (91 dB or more) but rare sensorineural hearing loss, uni- or bilateral. 
  • Acute unilateral deafness occurs in about 0.005% of cases
  • Thyroiditis, neuritis, hepatitis, myocarditis etc.
Mumps vaccine
  • 95 % effective live attenuated vaccine.
  • Widely-used live attenuated mumps vaccine strains include :
  • The Jeryl-Lynn
  • Contraindicated in pregnancy
  • Routine immunization:
  • For children over 1 year of age
  • Either alone or in combination with other virus vaccines
  • A second dose is recommended for children at 4-6 years of age i.e., before starting the school
Don’t Forget to Solve all the previous Year Question asked on Mumps Virus

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading